Taptiqom

Taptiqom combines timolol and tafluprost for ocular use to reduce intraocular pressure. This combination therapy is prescribed for conditions like glaucoma and ocular hypertension. It is designed for daily use to support eye health. Suitable for adults seeking effective pressure management.

Taptiqom is used to lower elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It combines two active ingredients that work together to improve fluid drainage from the eye. This helps reduce the risk of optic nerve damage and vision loss. It is typically used when single-agent therapy is insufficient.

After application, Taptiqom may reduce eye pressure within a few hours, with effects lasting up to 24 hours. Some users report temporary blurred vision or mild eye discomfort. These effects are generally mild and tend to diminish with continued use. Regular use helps maintain consistent pressure control.

Store Taptiqom in a cool, dry place away from light. Keep the container tightly closed when not in use. Avoid touching the dropper tip to prevent contamination. If you wear contact lenses, remove them before applying and wait 15 minutes before reinserting. Discard any unused solution after the expiration date.

Taptiqom may interact with other eye medications, especially those containing prostaglandins or beta-blockers. Combining it with oral beta-blockers could increase systemic effects like low blood pressure. Alcohol and certain medications may enhance dizziness or drowsiness. Consult a healthcare provider before using with other treatments.